Daniel P. Cahill

Active 1998–2025

137
Papers
33,174
Citations
78
h-index
132
i10-index

Citations

Citations per year for Daniel P. Cahill1987: 1 citations1993: 1 citations1998: 22 citations1999: 46 citations2000: 67 citations2001: 74 citations2002: 91 citations2003: 69 citations2004: 77 citations2005: 57 citations2006: 49 citations2007: 107 citations2008: 175 citations2009: 198 citations2010: 202 citations2011: 209 citations2012: 229 citations2013: 221 citations2014: 235 citations2015: 240 citations2016: 246 citations2017: 415 citations2018: 363 citations2019: 1,133 citations2020: 1,523 citations2021: 1,689 citations2022: 1,469 citations2023: 1,193 citations2024: 1,891 citations2025: 1,016 citations2026: 34 citations1988–1992: no citations, so these years are not shown1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,221 citing papers, 30.9% of this breakdownChina: 2,119 citing papers, 12.5% of this breakdownGermany: 1,063 citing papers, 6.3% of this breakdownUnited Kingdom: 1,004 citing papers, 5.9% of this breakdownItaly: 694 citing papers, 4.1% of this breakdownCanada: 610 citing papers, 3.6% of this breakdownFrance: 570 citing papers, 3.4% of this breakdownNetherlands: 477 citing papers, 2.8% of this breakdownJapan: 470 citing papers, 2.8% of this breakdownSwitzerland: 397 citing papers, 2.4% of this breakdownSpain: 390 citing papers, 2.3% of this breakdownAustralia: 359 citing papers, 2.1% of this breakdown
0%30.9%Other 20.9%

Fields

  • Medicine50.3%
  • Biochemistry, Genetics and Molecular Biology40.3%
  • Immunology and Microbiology4%
  • Neuroscience2.2%
  • Engineering0.9%
  • Materials Science0.5%
  • Other1.8%

Topics

  • Glioma Diagnosis and Treatment10.6%
  • Cancer Genomics and Diagnostics4.5%
  • Brain Metastases and Treatment3.2%
  • Single-cell and spatial transcriptomics2.8%
  • Epigenetics and DNA Methylation2.6%
  • Cancer, Hypoxia, and Metabolism2.6%
  • Other73.7%

Coauthors

All papers

Open in search
  1. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Haberler, René Geyeregger, Thomas Czech, Irene Slavc, Brian V. Nahed, William T. Curry, Bob S. Carter, Hiroaki Wakimoto, Priscilla K. Brastianos, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Maria Martinez‐Lage, Matthew P. Frosch, Ivan Stamenkovic, Nicolò Riggi, Esther Rheinbay, Michelle Monje, Orit Rozenblatt–Rosen, Daniel P. Cahill, Anoop P. Patel, Tony Hunter, Inder M. Verma, Keith L. Ligon, David N. Louis, Aviv Regev, B Bernstein, Itay Tirosh, Mario L. Suvà - Cell 2019 cited by 2,988

  2. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gad Getz, Orit Rozenblatt–Rosen, Daniel P. Cahill, Michelle Monje, B Bernstein, David N. Louis, Aviv Regev, Mario L. Suvà - Nature 2016 cited by 1,372

  3. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David N. Louis, B Bernstein, Aviv Regev, Mario L. Suvà - Science 2017 cited by 1,090

  4. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2019 cited by 558

  5. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 798

  6. Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard Colman, Erik P. Sulman, Kenneth Aldape - Cancer Cell 2013 cited by 1,133

  7. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gernot Poschet, Michael Weller, Matthias Preusser, Minou Nadji‐Ohl, Niklas Thon, Michael C. Burger, Patrick N. Harter, Miriam Ratliff, Richard P. Harbottle, Axel Benner, Daniel Schrimpf, Jürgen G. Okun, Christel Herold‐Mende, Şevin Turcan, Stefan Kaulfuß, Holger Hess‐Stumpp, Karen Bieback, Daniel P. Cahill, Karl H. Plate, Daniel Hänggi, Marion Dorsch, Mario L. Suvà, Barbara A. Niemeyer, Andreas von Deimling, Wolfgang Wick, Michael Platten - Nature Medicine 2018 cited by 537

  8. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew P. Frosch, David N. Louis, Gordon J. Freeman, Keith L. Ligon, Alexander Marson, E. Antonio Chiocca, David A. Reardon, Aviv Regev, Mario L. Suvà, Kai W. Wucherpfennig - Cell 2021 cited by 412

  9. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Y. Wen - Neuro-Oncology 2022 cited by 237

  10. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer‐Rachamimov, Matthew Meyerson, Levi A. Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn - Cancer Discovery 2015 cited by 1,136

  11. Patterns of somatic mutation in human cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, David Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P. Cahill, David N. Louis, Peter Goldstraw, Andrew G. Nicholson, Francis Brasseur, Leendert H. J. Looijenga, Barbara L. Weber, Yoke-Eng Chiew, Anna DeFazio, Mel Greaves, Anthony R. Green, Peter J. Campbell, Ewan Birney, Douglas F. Easton, Georgia Chenevix‐Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P. Andrew Futreal, Michael R. Stratton - Nature 2007 cited by 3,147

  12. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance

    Authors: , , , , , , , , , , , , , , , , , , , - Cell stem cell 2016 cited by 531

  13. Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2014 cited by 973

  14. Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 374

  15. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 781

  16. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

    Authors: , , , , , , , , , , , , , , - Science 2014 cited by 330

  17. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2015 cited by 445

  18. Evidence-based recommendations on categories for extent of resection in diffuse glioma

    Authors: , , , , , , , , - European Journal of Cancer 2021 cited by 208

  19. Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

    Authors: , , , , , , , , , , , - Cancer Cell 2011 cited by 709

  20. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Parker Merrill, Elizabeth R. Gerstner, Tracy T. Batchelor, Matthew P. Frosch, Ryan P. Frazier, Darrell R. Borger, A. John Iafrate, Bruce E. Johnson, Sandro Santagata, Matthias Preusser, Daniel P. Cahill, Scott L. Carter, Priscilla K. Brastianos - Nature Genetics 2020 cited by 302

  21. De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Quang‐Dé Nguyen, Sabina Signoretti, Stefan Gradl, Andreas Sutter, Michael Jeffers, Andreas Janzer, Mark A. Lehrman, Lauren G. Zacharias, Thomas P. Mathews, Julie-Aurore Losman, Timothy E. Richardson, Daniel P. Cahill, Ralph J. DeBerardinis, Keith L. Ligon, Lin Xu, Peter Ly, Nathalie Y.R. Agar, Kalil G. Abdullah, Isaac S. Harris, William G. Kaelin, Samuel K. McBrayer - Cancer Cell 2022 cited by 129

  22. Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology Advances 2022 cited by 74

  23. BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 135

  24. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 1,765